| Radon and lung cancer TK Sethi, MN El-Ghamry, GH Kloecker Clin Adv Hematol Oncol 10 (3), 157-164, 2012 | 143 | 2012 |
| Magnetic resonance imaging of tumor-associated macrophages: clinical translation M Aghighi, AJ Theruvath, A Pareek, LL Pisani, R Alford, AM Muehe, ... Clinical Cancer Research 24 (17), 4110-4118, 2018 | 87 | 2018 |
| Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome. DLHE Aghighi M, Boe J, Rosenberg J, Von Eyben R, Gawande RS, Petit P, Sethi ... Radiology, 2016 | 44 | 2016 |
| Breakthrough concepts in immune-oncology: cancer vaccines at the bedside S Roy, TK Sethi, D Taylor, YJ Kim, DB Johnson Journal of Leucocyte Biology 108 (4), 1455-1489, 2020 | 30 | 2020 |
| Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma T Sethi, V Nguyen, S Li, D Morgan, J Greer, N Reddy Therapeutic Advances in Hematology 8 (1), 13-20, 2017 | 25 | 2017 |
| Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma TK Sethi, AE Kovach, NS Grover, LC Huang, LA Lee, SM Rubinstein, ... Leukemia & lymphoma, 2019 | 15 | 2019 |
| Iron deficiency masquerading as idiopathic intracranial hypertension B Kaul, R Sivaramakrishnan, H Mahapatra, TK Sethi, R Ahlawat Case Reports 2009, bcr0620080346, 2009 | 15 | 2009 |
| Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics SD Gisriel, J Yuan, RC Braunberger, DLV Maracaja, X Chen, X Wu, ... Modern Pathology 35 (10), 1411-1422, 2022 | 13 | 2022 |
| How we treat advanced stage cutaneous T‐cell lymphoma–mycosis fungoides and Sézary syndrome TK Sethi, F Montanari, F Foss, N Reddy British Journal of Haematology 195 (3), 352-364, 2021 | 12 | 2021 |
| Outcomes from autologous hematopoietic cell transplantation versus chemotherapy alone for the management of light chain amyloidosis O Oke, T Sethi, S Goodman, S Phillips, I Decker, S Rubinstein, ... Biology of Blood and Marrow Transplantation 23 (9), 1473-1477, 2017 | 10 | 2017 |
| Histology-specific uses of tyrosine kinase inhibitors in non-gastrointestinal stromal tumor sarcomas TK Sethi, VL Keedy Current treatment options in oncology 17, 1-10, 2016 | 8 | 2016 |
| Impact of molecular features of diffuse Large b-cell lymphoma on treatment outcomes with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy BT Hill, CJ Roth, R Kositsky, T Dave, C Love, M McKinney, A Galal, ... Blood 138, 165, 2021 | 7 | 2021 |
| Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies TK Sethi, NM Reddy Leukemia & Lymphoma 60 (1), 6-18, 2019 | 7 | 2019 |
| Beyond anthracyclines: preemptive management of cardiovascular toxicity in the era of targeted agents for hematologic malignancies TK Sethi, B Basdag, N Bhatia, J Moslehi, NM Reddy Current Hematologic Malignancy Reports 12, 257-267, 2017 | 6 | 2017 |
| Trends in FDA cancer registration trial design over time, 1969-2020. JL Warner, TK Sethi, DR Rivera, NK Venepalli, TJ Osterman, AR Khaki, ... Journal of Clinical Oncology 38 (15_suppl), 2060-2060, 2020 | 4 | 2020 |
| Combination of nivolumab, lenalidomide and rituximab in relapsed/refractory non-germinal center diffuse large B cell lymphoma: results from a dose-escalation cohort T Sethi, AE Kovach, EF Mason, H Chen, T Moyo, OO Oluwole, D Morgan, ... Blood 134, 4100, 2019 | 4 | 2019 |
| Accelerated PET/MR Staging of Children with Cancer M Aghighi, C Klenk, S zanganeh, T Sethi, S luna-fineman, H Daldrup-Link Radiological Society of North America 2014 Scientific Assembly and Annual …, 2014 | 4 | 2014 |
| Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis M Di, JB Long, SK Kothari, T Sethi, AM Zeidan, NA Podoltsev, RM Shallis, ... Haematologica 108 (8), 2218, 2023 | 2 | 2023 |
| A multicenter, real‐world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus C Dittus, N Grover, T Sethi, JB Cohen, A Voloschin, J Rabadey, X Tan, ... EJHaem 3 (3), 734, 2022 | 2 | 2022 |
| EPOCH is a safe and effective treatment option for aggressive T-cell lymphomas T Sethi, R Gerstein, M Schiffer, K Amin, S Agarwal, FM Foss Blood 138, 4547, 2021 | 2 | 2021 |
